Preaxia Health Care Payment Systems Posts $857,028 Loss in H1 FY2026
Preaxia Health Care Payment Systems Inc., a healthcare payment systems company, reported an $857,028 net loss for the six months ending November 30, 2025. The company generated no revenue during the period.
Preaxia Health Care Payment Systems Inc., a Nevada-incorporated healthcare payment systems company, reported an $857,028 net loss for the six months ending November 30, 2025, compared to an $18,293 loss in the same period a year earlier. The company generated no revenue during either period. Read more earnings reports.
Operating expenses surged to $688,189 for the first half of fiscal 2026, up from $18,293 a year earlier. The increase included $307,605 in research and development spending, a category that showed zero expenditure in the prior-year period.
For the three months ending November 30, 2025, the company posted a net loss of $111,820, compared to a $13,666 loss in the same quarter last year. Operating expenses for the quarter totaled $112,055, up from $13,666 a year earlier.
Cash from operations consumed $113,720 during the six-month period, compared to $18,561 used a year earlier. The company deployed $70,608 in investing activities and raised $201,812 through financing activities. Cash and cash equivalents stood at $13,846 as of November 30, 2025, up from $165 a year earlier.
Total assets reached $143,636 at the end of the period, with property, plant and equipment accounting for $129,790. Total liabilities declined to $768,765 from $2,341,169 at the end of May 2025. Stockholders' deficit stood at $625,129 as of November 30, 2025.
The company nearly doubled its share count during the period, with common shares outstanding rising to 43,514,782 from 19,767,698 at the end of May 2025. The share increase contributed to an expansion in additional paid-in capital to $5,342,987 from $2,782,203.
Retained deficit widened to $6,067,418 from $5,210,390 over the same timeframe. Basic and diluted earnings per share came in at negative $0.02 for the six-month period, based on 39,201,810 weighted average shares outstanding.
Financial Summary
| Metric | H1 FY2026 | H1 FY2025 |
|---|---|---|
| Total Revenue | $0 | $0 |
| Operating Expenses | $688,189 | $18,293 |
| Net Loss | ($857,028) | ($18,293) |
| Cash from Operations | ($113,720) | ($18,561) |
| Total Assets | $143,636 | N/A |
| Stockholders' Deficit | ($625,129) | ($2,414,472) |
| EPS (Basic & Diluted) | ($0.02) | ($0.00) |